Search
Sinovac Pharmaceutical: Pursuing Listing on the Hong Kong Stock Exchange
2025-08-22 /
Read about 0 minute
Author：小编
Sinovac Pharmaceutical is poised to issue H-shares and seek listing on the Hong Kong Stock Exchange, a move aimed at fortifying its 'innovation + internationalization' strategy, expediting its global business expansion, and bolstering its overall competitiveness and international brand reputation. The definitive plan will undergo scrutiny by the company's board of directors and shareholders' meeting, and requires approval from pertinent regulatory bodies, thus entailing potential uncertainties in its final execution.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
